← Eichor
Condition: Abortion Medical Synced from ClinicalTrials.gov · July 28, 2026

Recruiting studies: Abortion Medical

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Point of Care Tests in the Management of Very Early Medical Abortion
Phase N/A · 3 location(s) · University of Edinburgh · NCT07417787
Comparison of Rate of Complete Abortion Between Letrozole Plus Misoprostol vs Misoprostol Alone
NA · 1 location(s) · Queen Savang Vadhana Memorial Hospital, Thailand · NCT05940233
Use of Aromatase Inhibitor Before Misoprostol in Medical Termination of Miscarriage
NA · 1 location(s) · Aswan University · NCT07109947
Effectiveness of Anti-Inflammatory Drugs for Preventing Pain Versus Treating Pain During Medical Abortion From 13 to 22
NA · 1 location(s) · Le Thi Kieu Trang · NCT06696573
Foley Balloon for Cervical Preparation Before Dilation and Evacuation
NA · 1 location(s) · Stony Brook University · NCT06850974
Evaluation of Telemedicine Medical Abortion Service in Ecuador
Phase N/A · 3 location(s) · Gynuity Health Projects · NCT06270056
Mechanisms and Factors Responsible for the Inhibition of Transposons During Fetal Gonad Development in Humans
Phase N/A · 1 location(s) · Centre Hospitalier Universitaire Dijon · NCT02171845
The Use of Letrozole or Mifepristone for Pretreatment of Medical Termination of Pregnancy
Phase 4 · 1 location(s) · KK Women's and Children's Hospital · NCT05341817
Mifepristone vs Misoprostol
Phase 1 · 1 location(s) · Montefiore Medical Center · NCT06502158
Success Rates of Expectant vs. Medical Management for Retained Products After First-Trimester Abortion: Randomized Contr
NA · 1 location(s) · Yael Yagur · NCT07534982
Randomized Study of a Dematerialized Management for Post-Emergency Gynecological Follow-Up
NA · 1 location(s) · Assistance Publique - Hôpitaux de Paris · NCT06615843
Late-term Abortions Between 14 and 16 Weeks of Gestation: Comparison of Hemorrhagic Risks in Surgical vs. Medical Aborti
Phase N/A · 1 location(s) · University Hospital, Strasbourg, France · NCT07335939
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.